120 results
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
8 Aug 12
Regulation FD Disclosure
12:00am
Tools to Advance Life Science Research
and Regenerative Medicine
NASDAQ HBIO
August 2012
Exhibit 99.1
Copyright © Harvard Bioscience 2012
Safe … or potential acquisitions, the outlook for the life
sciences industry and the field of regenerative medicine, opportunities or potential opportunities
8-K
EX-99
HBIO
Harvard Bioscience Inc.
11 Dec 12
Other Events
12:00am
EXHIBIT 99.1
Harvard Bioscience, Inc. Announces Filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology, Inc.
HOLLISTON … of tools to advance life science research and regenerative medicine, today announced that its wholly-owned subsidiary, Harvard Apparatus Regenerative
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
15 Apr 11
Excerpts from Annual Report
12:00am
Exhibit 99.1
EXCERPTS FROM ANNUAL REPORT
Dear Fellow Shareholders
2010 was a landmark year for HBIO with the development of our new Regenerative … Scientific in 2009, expansion of our sales force and the introduction of several major new products.
We developed 3 novel Regenerative Medicine Device
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
23 Apr 10
Regulation FD Disclosure
12:00am
the emerging field of regenerative medicine with the license of a novel bioreactor, which was previously used to perform the world’s first human transplant … engineered hollow organs. We also began collaborations with several key scientists working to advance regenerative medicine.
We continued
8-K
EX-99.2
HBIO
Harvard Bioscience Inc.
5 Aug 13
Results of Operations and Financial Condition
12:00am
EXHIBIT 99.2
HBIO Subsidiary Harvard Apparatus Regenerative Technology, Inc. Files Form 10 Registration Statement for Planned Spin-Off
HOLLISTON … of tools to advance life science research and regenerative medicine, today announced that its wholly-owned regenerative medicine device subsidiary, Harvard
8-K
EX-99.1
mejsp95 fm
29 Apr 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99
l6dfnjvuh0
7 May 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99
hlf9db0q
1 Mar 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99
ap4k e4m6
4 Nov 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99
5tjtnab6
1 Nov 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
w4yj7e toyg
29 Apr 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99
2k1cw4pta qj5xd
5 Aug 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
4zrbhjrdm68s
25 Feb 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
1g8x 8q15
6 Nov 13
Harvard Bioscience Becomes Pure-Play Developer, Manufacturer and Marketer of Tools for Life Science Research
12:00am
8-K
EX-99
ycftplv
31 Oct 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99
5f6129omy1ig2w
4 Mar 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99
n423y42osib tg7qr6
3 Aug 12
Results of Operations and Financial Condition
12:00am
8-K
q5z6niweq
16 Oct 13
Departure of Directors or Certain Officers
12:00am
8-K
t1pqjv maq9kacknc7p
6 Nov 13
Harvard Bioscience Becomes Pure-Play Developer, Manufacturer and Marketer of Tools for Life Science Research
12:00am
8-K
EX-99.2
6dsqtfwr78
16 Oct 13
Departure of Directors or Certain Officers
12:00am